無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙SALE
市場調査レポート

心臓再同期療法用ペースメーカー (CRT-P) の世界市場:2016〜2020年

Global Cardiac Resynchronization Therapy Pacemaker Market 2016-2020

発行 TechNavio (Infiniti Research Ltd.) 商品コード 363484
出版日 ページ情報 英文 48 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.11円で換算しております。
Back to Top
心臓再同期療法用ペースメーカー (CRT-P) の世界市場:2016〜2020年 Global Cardiac Resynchronization Therapy Pacemaker Market 2016-2020
出版日: 2016年07月15日 ページ情報: 英文 48 Pages
概要

心臓再同期療法用ペースメーカー (CRT-P) は最新型のペースメーカーの一種で、血流や心室の動きを観察して、同時に収縮するように心調律を整える働きをします。通常のペースメーカーと異なり、CRT-Pにはリード (導線) があり、2本の右心室と左心室の両方につながっています。世界のCRT-P市場は2016〜2020年にかけて、8.17%のCAGR (複合年間成長率) で成長する見通しです。

当レポートでは、世界の心臓再同期療法用ペースメーカー (CRT-P) 市場について分析し、市場の概要や構造、市場規模の動向 (今後5年間の予測値)、用途別・地域別の詳細動向、市場の促進・抑制要因とその影響力、主要企業のプロファイル、今後の市場機会などを調査・推計しております。

第1章 エグゼクティブ・サマリー

  • 分析結果の概略

第2章 分析範囲

  • 分析概要
  • 大手ベンダーの主要製品

第3章 市場分析の手法

  • 分析手法
  • 経済指標

第4章 イントロダクション

  • 市場動向の概略

第5章 心臓再同期療法用ペースメーカー (CRT-P) の市場環境

  • 市場概要
  • 市場規模とその予測
  • ファイブフォース分析

第6章 CRT-Pとその埋め込み手術のコスト分析

第7章 地域区分

  • 南北アメリカのCRT-P市場
  • 欧州・中東・アフリカ諸国 (EMEA) のCRT-P市場
  • アジア太平洋地域のCRT-P市場

第8章 主要国市場

  • 米国
  • フランス
  • 英国
  • ドイツ

第9章 心臓再同期療法用ペースメーカー (CRT-P) の世界市場:促進要因

  • 心血管疾患の発症率
  • 政府の支援による啓発プログラム
  • 低侵襲的処置の導入
  • アジア太平洋地域でのCRT-P需要

第10章 促進要因の影響力

第11章 心臓再同期療法用ペースメーカー (CRT-P) の世界市場:課題

  • 代替的手段の登場
  • 熟達した人材の不足
  • 潜在的な合併症のリスク
  • 小児患者の場合のCRT-Pの限界

第12章 促進要因・課題の影響力

第13章 心臓再同期療法用ペースメーカー (CRT-P) の世界市場:動向

  • 研究開発 (R&D) および治験への注目
  • ロボット支援型心臓手術の人気
  • リード無しCRT-Pへの注目

第14章 ベンダー環境

  • 競争シナリオ

第15章 主要ベンダーの分析

  • BIOTRONIK
  • Boston Scientific
  • LivaNova
  • Medtronic
  • St. Jude Medical

第16章 付録

  • 略語集

第17章 Technavioについて

図表
  • Exhibit 01: Product offerings
  • Exhibit 02: Global CRT-P market 2015-2020 ($ millions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Cost comparison of CRT-P and ICD and their implantation
  • Exhibit 05: Global CRT-P market segmentation by geography 2015
  • Exhibit 06: Global CRT-P market segmentation by geography 2020
  • Exhibit 07: Global CRT-P market segmentation by geography 2015-2020
  • Exhibit 08: CRT-P market in Americas 2015-2020 ($ millions)
  • Exhibit 09: CRT-P market in EMEA 2015-2020 ($ millions)
  • Exhibit 10: CRT-P market in APAC 2015-2020 ($ millions)
  • Exhibit 11: CRT-P market in US 2015-2020 ($ millions)
  • Exhibit 12: CRT-P market in France 2015-2020 ($ millions)
  • Exhibit 13: CRT-P market in UK 2015-2020 ($ millions)
  • Exhibit 14: CRT-P market in Germany 2015-2020 ($ millions)
  • Exhibit 15: Impact of drivers
  • Exhibit 16: Impact of drivers and challenges
  • Exhibit 17: BIOTRONIK: Product portfolio
  • Exhibit 18: BIOTRONIK: Key takeaways
  • Exhibit 19: Boston Scientific: Cardiac rhythm management segmentation by revenue 2015
  • Exhibit 20: Boston Scientific: Cardiac rhythm management segmentation by revenue 2014 and 2015 ($ millions)
  • Exhibit 21: Boston Scientific: Geographical segmentation of cardiac rhythm management by revenue 2015
  • Exhibit 22: Key takeaways: Boston Scientific
  • Exhibit 23: LivaNova: Product portfolio
  • Exhibit 24: LivaNova: Key takeaways
  • Exhibit 25: Medtronic: Product portfolio
  • Exhibit 26: Key takeaways: Medtronic
  • Exhibit 27: St. Jude Medical: Product portfolio
  • Exhibit 28: Key takeaways: St. Jude Medical
目次
Product Code: IRTNTR8951

About Cardiac Resynchronization Therapy-pacemaker (CRT-P)

CRT-Ps are an advanced implantable form of conventional pacemakers. They help the heart function efficiently by monitoring its signals and coordinating with the ventricles to contract at the same time. These devices resynchronize the heart's rhythm to improve breathlessness and fatigue, and avoid dizziness and fainting in individuals.

Physicians surgically implant the CRT-P under the skin, below the collarbone. They connect the electrical leads through a blood vessel into the heart. Unlike conventional pacemakers, CRT-Ps have two leads: one placed into the right ventricle and the other in the right atrium. An extra lead is implanted on the left side of the heart to stimulate the left ventricle, assisting the heart to pump efficiently.

Technavio's analysts forecast the global cardiac resynchronization therapy-pacemaker (CRT-P) market to grow at a CAGR of 8.17% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global cardiac resynchronization therapy-pacemaker (CRT-P) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of CRT-Ps.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Cardiac Resynchronization Therapy-Pacemaker (CRT-P) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • BIOTRONIK
  • Boston Scientific
  • LivaNova
  • Medtronic
  • St. Jude Medical

Market driver

  • Implementation of minimally invasive procedures
  • For a full, detailed list, view our report

Market challenge

  • Risk of potential complications
  • For a full, detailed list, view our report

Market trend

  • Popularity of robot-assisted cardiac surgery
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Cost analysis of CRT-Ps and implantation

PART 07: Geographical segmentation

  • CRT-P market in Americas
  • CRT-P market in EMEA
  • CRT-P market in APAC

PART 08: Key leading countries

  • US
  • France
  • UK
  • Germany

PART 09: Market drivers

  • Incidence of cardiovascular diseases
  • Government-aided awareness programs
  • Implementation of minimally invasive procedures
  • Demand for CRT-Ps in APAC

PART 10: Impact of drivers

PART 11: Market challenges

  • Presence of alternatives
  • Lack of skilled personnel
  • Risk of potential complications
  • Limitations of CRT-Ps in pediatric patients

PART 12: Impact of drivers and challenges

PART 13: Market trends

  • Focus on R&D and clinical trials
  • Popularity of robot-assisted cardiac surgery
  • Focus on leadless CRT-Ps

PART 14: Vendor landscape

  • Competitive scenario

PART 15: Key vendor analysis

  • BIOTRONIK
  • Boston Scientific
  • LivaNova
  • Medtronic
  • St. Jude Medical

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

Back to Top